Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Biogen
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Rituxan
(rituximab) / Roche
Tysabri
(natalizumab) / Biogen, Royalty
Avonex
(recombinant IFN-β-1a) / Biogen
Plegridy
(PEG-interferon β-1a) / Biogen
Fumaderm
(dimethyl fumarate) / Biogen